Participation at the 35th ESICM Annual Congress
We participated at the 35th annual congress of the ESICM on October 25, 2022 in Paris.
Ambre Loïodice presented a poster on the effect of adequacy of antibiotic therapy for hospital-acquired bacteraemia on patient prognosis using data from the EUROBACT 2 study. The analyzes are based on causal inference methods.
The objective is to determine the effect of adequate early antibiotic therapy on 28-day mortality in patients followed up at least 3 days after the onset of nosocomial bacteremia.
Participation in the 4th day of the SPIADI national mission
We are very happy to have participated with Dr. Buetti in the 4th day of the SPIADI national mission which was held on October 18, 2022 in Tours.
At this congress, we presented our connected health project that we had begun to unveil to you before the summer… The DEEPCATH project!
SPIADI is a Surveillance and Prevention Program for Infections Associated with Invasive Devices set up by the CPIAS. Its objective is to implement the national policy for managing the risk of infection associated with invasive devices throughout the course of care, by combining the 3 essential aspects of monitoring, prevention and evaluation. https://www.spiadi.fr/missionday
If you want to participate at the DEEPCATH project, do not hesitate to register https://deepcath.com.
FAMI-LIFE
Since August 2, 2019, already 403 patients are included in the study “FAMI-LIFE” out of 500 planned. The main objective of this study is to determine […]
Secondary subsidiary
A secondary subsidiary recently opened in the city of Saint-Marcellin (38160) at the following address: 6 bis avenue de Romans.
